---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008137"
form_type: "8-K"
ticker: "MAIA"
cik: "0001878313"
company_name: "MAIA Biotechnology, Inc."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:59:10.539200+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MAIA Biotechnology raises ~$1.43M private placement, total $4.1M from two deals

## Summary
- 952,300 shares at $1.50 each; warrants exercisable at $1.85 for 6 years, starting 1 year post-issuance.
- Company directors participate (58,333 shares); proceeds to fund Part C of Phase 2 THIO-101 trial and working capital.
- Combined gross proceeds from this and a separate $2.7M placement (closed Feb 24) reach $4.1M.
- Private placement expected to close on or about February 26, 2025, subject to customary conditions.

## SEC filing metadata
- accession: 0001493152-25-008137
- form_type: 8-K
- ticker: MAIA
- cik: 0001878313
- company_name: MAIA Biotechnology, Inc.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1878313/000149315225008137/0001493152-25-008137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1878313/000149315225008137/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008137
- JSON: https://secwatch.observer/filing/0001493152-25-008137.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008137.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.